Anavex Life Sciences Statistics
Total Valuation
AVXL has a market cap or net worth of $242.80 million. The enterprise value is $111.05 million.
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVXL has 92.67 million shares outstanding. The number of shares has increased by 2.61% in one year.
| Current Share Class | 92.67M |
| Shares Outstanding | 92.67M |
| Shares Change (YoY) | +2.61% |
| Shares Change (QoQ) | +3.65% |
| Owned by Insiders (%) | 3.12% |
| Owned by Institutions (%) | 43.66% |
| Float | 89.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.92 |
| P/TBV Ratio | 1.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.87
| Current Ratio | 20.87 |
| Quick Ratio | 20.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.63% and return on invested capital (ROIC) is -23.33%.
| Return on Equity (ROE) | -33.63% |
| Return on Assets (ROA) | -21.56% |
| Return on Invested Capital (ROIC) | -23.33% |
| Return on Capital Employed (ROCE) | -35.01% |
| Weighted Average Cost of Capital (WACC) | 10.42% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.17M |
| Employee Count | 34 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AVXL has paid $18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.16% in the last 52 weeks. The beta is 1.12, so AVXL's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -72.16% |
| 50-Day Moving Average | 2.95 |
| 200-Day Moving Average | 4.83 |
| Relative Strength Index (RSI) | 46.47 |
| Average Volume (20 Days) | 1,661,832 |
Short Selling Information
The latest short interest is 18.83 million, so 20.32% of the outstanding shares have been sold short.
| Short Interest | 18.83M |
| Short Previous Month | 19.23M |
| Short % of Shares Out | 20.32% |
| Short % of Float | 20.98% |
| Short Ratio (days to cover) | 18.49 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -44.33M |
| Pretax Income | -39.93M |
| Net Income | -39.95M |
| EBITDA | n/a |
| EBIT | -44.33M |
| Earnings Per Share (EPS) | -$0.46 |
Full Income StatementBalance Sheet
The company has $131.75 million in cash and n/a in debt, giving a net cash position of $131.75 million or $1.42 per share.
| Cash & Cash Equivalents | 131.75M |
| Total Debt | n/a |
| Net Cash | 131.75M |
| Net Cash Per Share | $1.42 |
| Equity (Book Value) | 126.62M |
| Book Value Per Share | 1.37 |
| Working Capital | 126.62M |
Full Balance SheetCash Flow
| Operating Cash Flow | -34.08M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -34.08M |
| FCF Per Share | -$0.37 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |